Overcoming doxorubicin resistance in cancer: siRNA-loaded nanoarchitectures for cancer gene therapy
出版年份 2022 全文链接
标题
Overcoming doxorubicin resistance in cancer: siRNA-loaded nanoarchitectures for cancer gene therapy
作者
关键词
Doxorubicin, siRNA, Cancer chemotherapy, Smart nanoparticles, Drug resistance, Gene therapy
出版物
LIFE SCIENCES
Volume 298, Issue -, Pages 120463
出版商
Elsevier BV
发表日期
2022-03-07
DOI
10.1016/j.lfs.2022.120463
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- HIF-1 and NRF2; Key Molecules for Malignant Phenotypes of Pancreatic Cancer
- (2022) Shin Hamada et al. Cancers
- PLGA/PCADK Composite Microspheres Containing Hyaluronic Acid–Chitosan siRNA Nanoparticles: A Rational Design for Rheumatoid Arthritis Therapy
- (2021) Menghui Zhao et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Combined and selective miR-21 silencing and doxorubicin delivery in cancer cells using tailored DNA nanostructures
- (2021) Sofia Raniolo et al. Cell Death & Disease
- Tumour-Targeted and Redox-Responsive Mesoporous Silica Nanoparticles for Controlled Release of Doxorubicin and an siRNA Against Metastatic Breast Cancer
- (2021) Jialang Zhuang et al. International Journal of Nanomedicine
- Au-siRNA@ aptamer nanocages as a high-efficiency drug and gene delivery system for targeted lung cancer therapy
- (2021) Yuming Yang et al. JOURNAL OF NANOBIOTECHNOLOGY
- Combination Therapy of Breast Cancer by Codelivery of Doxorubicin and Survivin siRNA Using Polyethylenimine Modified Silk Fibroin Nanoparticles
- (2021) Parisa Norouzi et al. ACS Biomaterials-Science & Engineering
- The multifaceted role of NRF2 in cancer progression and cancer stem cells maintenance
- (2021) Bo-Hyun Choi et al. ARCHIVES OF PHARMACAL RESEARCH
- PLGA nanoparticles containing α-fetoprotein siRNA induce apoptosis and enhance the cytotoxic effects of doxorubicin in human liver cancer cell line
- (2021) Theeraphong Pho-iam et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Nanoparticles for Oral Cancer Diagnosis and Therapy
- (2021) Weiping Zheng et al. BIOINORGANIC CHEMISTRY AND APPLICATIONS
- MicroRNAs as the critical regulators of Doxorubicin resistance in breast tumor cells
- (2021) Amir Sadra Zangouei et al. Cancer Cell International
- Functionalised molybdenum disulfide nanosheets for co-delivery of doxorubicin and siRNA for combined chemo/gene/photothermal therapy on multidrug-resistant cancer
- (2021) Guo Li et al. JOURNAL OF PHARMACY AND PHARMACOLOGY
- Cancer stem cells in colorectal cancer and the association with chemotherapy resistance
- (2021) Xue Lei et al. MEDICAL ONCOLOGY
- Development of New Targeted Inulin Complex Nanoaggregates for siRNA Delivery in Antitumor Therapy
- (2021) Gennara Cavallaro et al. MOLECULES
- Co-delivery of CPP decorated doxorubicin and CPP decorated siRNA by NGR-modified nanobubbles for improving anticancer therapy
- (2021) Rui Ma et al. PHARMACEUTICAL DEVELOPMENT AND TECHNOLOGY
- Silencing STAT3 enhances sensitivity of cancer cells to doxorubicin and inhibits tumor progression
- (2021) Navneet Joshi et al. LIFE SCIENCES
- Role of NRF2 in Lung Cancer
- (2021) Miriam Sánchez-Ortega et al. Cells
- Prolactin and endocrine therapy resistance in breast cancer: The next potential hope for breast cancer treatment
- (2021) Yuan Li et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Endocytosis of abiotic nanomaterials and nanobiovectors: Inhibition of membrane trafficking
- (2021) Pooyan Makvandi et al. Nano Today
- Nanoparticles for Ferroptosis Therapy in Cancer
- (2021) Nadia Zaffaroni et al. Pharmaceutics
- MiR-451a attenuates doxorubicin resistance in lung cancer via suppressing epithelialmesenchymal transition (EMT) through targeting c-Myc
- (2020) Li Tao et al. BIOMEDICINE & PHARMACOTHERAPY
- Aptamers, the Nucleic Acid Antibodies, in Cancer Therapy
- (2020) Zhaoying Fu et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Inhibition of chemotherapy-related breast tumor EMT by application of redox-sensitive siRNA delivery system CSO-ss-SA/siRNA along with doxorubicin treatment
- (2020) Xuan Liu et al. Journal of Zhejiang University-SCIENCE B
- Monoclonal Antibody 2C5-Modified Mixed Dendrimer Micelles for Tumor-Targeted Codelivery of Chemotherapeutics and siRNA
- (2020) Jiayi Pan et al. MOLECULAR PHARMACEUTICS
- Repurposing of drugs: An attractive pharmacological strategy for cancer therapeutics
- (2020) Anuradha Kirtonia et al. SEMINARS IN CANCER BIOLOGY
- Autophagy-modulating phytochemicals in cancer therapeutics: Current evidences and future perspectives
- (2020) Srimanta Patra et al. SEMINARS IN CANCER BIOLOGY
- Enhancing chemosensitivity of wild-type and drug-resistant MDA-MB-231 triple-negative breast cancer cell line to doxorubicin by silencing of STAT 3, Notch-1, and β-catenin genes
- (2020) Arwa Alkaraki et al. Breast Cancer
- Anti-Epcam Aptamer (Syl3c)-Functionalized Liposome for Targeted Delivery Of Doxorubicin: In Vitro And In Vivo Antitumor Studies in Mice Bearing C26 Colon Carcinoma
- (2020) Mohammad Mashreghi et al. Nanoscale Research Letters
- KLHL22 Regulates the EMT and Proliferation in Colorectal Cancer Cells in Part via the Wnt/β-Catenin Signaling Pathway
- (2020) Yi Song et al. Cancer Management and Research
- Vitexin abrogates invasion and survival of hepatocellular carcinoma cells through targeting STAT3 signaling pathway
- (2020) Jong Hyun Lee et al. BIOCHIMIE
- Inhibition of Wnt/β-catenin pathway reverses multi-drug resistance and EMT in Oct4+/Nanog+ NSCLC cells
- (2020) Liyun Liu et al. BIOMEDICINE & PHARMACOTHERAPY
- Chitosan based pH-responsive polymeric prodrug vector for enhanced tumor targeted co-delivery of doxorubicin and siRNA
- (2020) Tingsheng Yan et al. CARBOHYDRATE POLYMERS
- Conjugation of Doxorubicin to siRNA Through Disulfide-based Self-immolative Linkers
- (2020) Florian Gauthier et al. MOLECULES
- Doxorubicin conjugated innovative 16-mer DNA aptamer based annexin A1 targeted anti-cancer drug delivery
- (2020) Rohit Bavi et al. Molecular Therapy-Nucleic Acids
- In silico and in vitro identification of secoisolariciresinol as a re-sensitizer of P-glycoprotein-dependent doxorubicin-resistance NCI/ADR-RES cancer cells
- (2020) Mohamed A. Morsy et al. PeerJ
- LncRNA NORAD accelerates the progression and doxorubicin resistance of neuroblastoma through up-regulating HDAC8 via sponging miR-144-3p
- (2020) Baiqi Wang et al. BIOMEDICINE & PHARMACOTHERAPY
- Doxorubicin delivered by redox-responsive Hyaluronic Acid–Ibuprofen prodrug micelles for treatment of metastatic breast cancer
- (2020) Zhuodong Chai et al. CARBOHYDRATE POLYMERS
- Charge reversible hyaluronic acid-modified dendrimer-based nanoparticles for siMDR-1 and doxorubicin co-delivery
- (2020) Xin Zhang et al. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS
- New perspectives in triple-negative breast cancer therapy based on treatments with TGFβ1 siRNA and doxorubicin
- (2020) Cristina Alexandra Ciocan-Cȃrtiţă et al. MOLECULAR AND CELLULAR BIOCHEMISTRY
- The AKT/GSK3-Mediated Slug Expression Contributes to Oxaliplatin Resistance in Colorectal Cancer via Upregulation of ERCC1
- (2020) Wei Wei et al. ONCOLOGY RESEARCH
- Transient IGF-1R inhibition combined with osimertinib eradicates AXL-low expressing EGFR mutated lung cancer
- (2020) Rong Wang et al. Nature Communications
- Development of a Hyaluronic Acid-Based Nanocarrier Incorporating Doxorubicin and Cisplatin as a pH-Sensitive and CD44-Targeted Anti-Breast Cancer Drug Delivery System
- (2020) Tao Yu et al. Frontiers in Pharmacology
- Advances in Lipid Nanoparticles for mRNA-Based Cancer Immunotherapy
- (2020) Maria L. Guevara et al. Frontiers in Chemistry
- Exosome-mediated Hic-5 regulates proliferation and apoptosis of osteosarcoma via Wnt/β-catenin signal pathway
- (2020) Liansheng Sha et al. Aging-US
- Hyaluronic acid wreathed, trio-stimuli receptive and on-demand triggerable nanoconstruct for anchored combinatorial cancer therapy
- (2020) Kishwor Poudel et al. CARBOHYDRATE POLYMERS
- Doxorubicin-loaded folate-mediated pH-responsive micelle based on Bletilla striata polysaccharide: Release mechanism, cellular uptake mechanism, distribution, pharmacokinetics, and antitumor effects
- (2020) Guangyuan Zhang et al. INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES
- Inhibition of AKT-Signaling Sensitizes Soft Tissue Sarcomas (STS) and Gastrointestinal Stromal Tumors (GIST) to Doxorubicin via Targeting of Homology-Mediated DNA Repair
- (2020) Sergei Boichuk et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- The pleiotropic role of transcription factor STAT3 in oncogenesis and its targeting through natural products for cancer prevention and therapy
- (2020) Manoj Garg et al. MEDICINAL RESEARCH REVIEWS
- siRNA-mediated silencing of CD44 delivered by Jet Pei enhanced Doxorubicin chemo sensitivity and altered miRNA expression in human breast cancer cell line (MDA-MB468)
- (2020) Fatemeh Vahidian et al. MOLECULAR BIOLOGY REPORTS
- Lactoferrin/phenylboronic acid-functionalized hyaluronic acid nanogels loading doxorubicin hydrochloride for targeting glioma
- (2020) Mei Zhang et al. CARBOHYDRATE POLYMERS
- Harnessing hyaluronic acid-based nanoparticles for combination therapy: A novel approach for suppressing systemic inflammation and to promote antitumor macrophage polarization
- (2020) Vignesh K. Rangasami et al. CARBOHYDRATE POLYMERS
- Engineered histidine-enriched facial lipopeptides for enhanced intracellular delivery of functional siRNA to triple negative breast cancer cells.
- (2019) Abhijit Biswas et al. ACS Applied Materials & Interfaces
- Liver-Targeted Combination Therapy Basing on Glycyrrhizic Acid-Modified DSPE-PEG-PEI Nanoparticles for Co-delivery of Doxorubicin and Bcl-2 siRNA
- (2019) Guixiang Tian et al. Frontiers in Pharmacology
- Facile Hydrophobization of siRNA with Anticancer Drug for Non-Cationic Nanocarrier-Mediated Systemic Delivery
- (2019) Congfei Xu et al. NANO LETTERS
- Application of Box-Behnken design in the preparation, optimization and in-vitro evaluation of self-assembly based Tamoxifen and Doxorubicin loaded dual drug loaded niosomes for combinatorial breast cancer treatment
- (2019) Pratik Kulkarni et al. JOURNAL OF PHARMACEUTICAL SCIENCES
- Inhibition of the deubiquitinase USP9x induces pre-B cell homeobox 1 (PBX1) degradation and thereby stimulates prostate cancer cell apoptosis
- (2019) Yan Liu et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- D-α-tocopherol polyethylene glycol 1000 succinate-modified liposomes with an siRNA corona confer enhanced cellular uptake and targeted delivery of doxorubicin via tumor priming
- (2019) Xi Tan et al. International Journal of Nanomedicine
- Polyamidoamine dendrimers-based nanomedicine for combination therapy with siRNA and chemotherapeutics to overcome multidrug resistance
- (2019) Jiayi Pan et al. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS
- Targeting autophagy using natural compounds for cancer prevention and therapy
- (2019) Shuo Deng et al. CANCER
- The siRNAsome: A Cation-Free and Versatile Nanostructure for siRNA and Drug Co-delivery
- (2019) Meng Zheng et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- In Vitro and In Vivo Co-delivery of siRNA and Doxorubicin by Folate-PEG-Appended Dendrimer/Glucuronylglucosyl-β-Cyclodextrin Conjugate
- (2019) Ahmed Fouad Abdelwahab Mohammed et al. AAPS Journal
- pH/Redox Dual-Responsive Polyplex with Effective Endosomal Escape for Codelivery of siRNA and Doxorubicin against Drug-Resistant Cancer Cells
- (2019) Yan Gao et al. ACS Applied Materials & Interfaces
- Transferrin Functionization Elevates Transcytosis of Nanogranules across Epithelium by Triggering Polarity-Associated Transport Flow and Positive Cellular Feedback Loop
- (2019) Dan Yang et al. ACS Nano
- Quick synthesis of a novel combinatorial delivery system of siRNA and doxorubicin for a synergistic anticancer effect
- (2019) Mengchun Chen et al. International Journal of Nanomedicine
- Cancer cell membrane cloaking nanoparticles for targeted co-delivery of doxorubicin and PD-L1 siRNA
- (2019) Mushi Chen et al. Artificial Cells Nanomedicine and Biotechnology
- Downregulation of STAT3, β-Catenin, and Notch-1 by Single and Combinations of siRNA Treatment Enhance Chemosensitivity of Wild Type and Doxorubicin Resistant MCF7 Breast Cancer Cells to Doxorubicin
- (2019) Walhan Alshaer et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Doxorubicin and siRNA-PD-L1 co-delivery with T7 modified ROS-sensitive nanoparticles for tumor chemoimmunotherapy
- (2019) Wen-jun Wan et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- miR-330 suppresses EMT and induces apoptosis by downregulating HMGA2 in human colorectal cancer
- (2019) Behzad Mansoori et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Peptide-based targeted polymeric nanoparticles for siRNA delivery
- (2019) Waleed M Hussein et al. NANOTECHNOLOGY
- The Lysosome Signaling Platform: Adapting With the Times
- (2019) Subothan Inpanathan et al. Frontiers in Cell and Developmental Biology
- Natural product-based nanoformulations for cancer therapy: Opportunities and challenges
- (2019) Dharambir Kashyap et al. SEMINARS IN CANCER BIOLOGY
- Aptamer-Based Erythrocyte-Derived Mimic Vesicles Loaded with siRNA and Doxorubicin for the Targeted Treatment of Multidrug-Resistant Tumors
- (2019) Tengfei Wang et al. ACS Applied Materials & Interfaces
- IL-10 knockdown with siRNA enhances the efficacy of Doxorubicin chemotherapy in EBV-positive tumors by inducing lytic cycle via PI3K/p38 MAPK/NF-kB pathway
- (2019) Li Gao et al. CANCER LETTERS
- Inhibition of TFF3 Enhances Sensitivity—and Overcomes Acquired Resistance—to Doxorubicin in Estrogen Receptor-Positive Mammary Carcinoma
- (2019) Han Poh et al. Cancers
- siRNA release kinetics from polymeric nanoparticles correlate with RNAi efficiency and inflammation therapy via oral delivery
- (2019) Chunbai He et al. Acta Biomaterialia
- Overcoming Multidrug Resistance by Codelivery of MDR1-Targeting siRNA and Doxorubicin Using EphA10-Mediated pH-Sensitive Lipoplexes: In Vitro and In Vivo Evaluation
- (2018) Jiulong Zhang et al. ACS Applied Materials & Interfaces
- On the Formation and Morphology of Lipid Nanoparticles Containing Ionizable Cationic Lipids and siRNA
- (2018) Jayesh A. Kulkarni et al. ACS Nano
- Co-Delivery of Doxorubicin and Anti-BCL-2 siRNA by pH-Responsive Polymeric Vector to Overcome Drug Resistance in In Vitro and In Vivo HepG2 Hepatoma Model
- (2018) Weitong Sun et al. BIOMACROMOLECULES
- Receptor mediated transcytosis in biological barrier: The influence of receptor character and their ligand density on the transmembrane pathway of active-targeting nanocarriers
- (2018) Xiaoning Song et al. BIOMATERIALS
- Non-viral based miR delivery and recent developments
- (2018) Annalise Elizabeth Labatut et al. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS
- Suppression of p53R2 gene expression with specific siRNA sensitizes HepG2 cells to doxorubicin
- (2018) Ako Azimi et al. GENE
- Doxorubicin and anti-VEGF siRNA co-delivery via nano-graphene oxide for enhanced cancer therapy in vitro and in vivo
- (2018) Qi Sun et al. International Journal of Nanomedicine
- Codelivery of doxorubicin and JIP1 siRNA with novel EphA2-targeted PEGylated cationic nanoliposomes to overcome osteosarcoma multidrug resistance
- (2018) Fateme Haghiralsadat et al. International Journal of Nanomedicine
- Semiconducting Polymer Nanocavities: Porogenic Synthesis, Tunable Host-Guest Interactions, and Enhanced Drug/siRNA Delivery
- (2018) Haobin Chen et al. Small
- HMGA2 enhances 5-fluorouracil chemoresistance in colorectal cancer via the Dvl2/Wnt pathway
- (2018) Xi Xu et al. Oncotarget
- Reduction/photo dual-responsive polymeric prodrug nanoparticles for programmed siRNA and doxorubicin delivery
- (2018) Ming Wu et al. Biomaterials Science
- Chemotherapy with si-RNA and Anti-Cancer Drugs
- (2018) Kamaljeet Kaur et al. Current Drug Delivery
- Dual-Responsive Core Crosslinking Glycopolymer-Drug Conjugates Nanoparticles for Precise Hepatocarcinoma Therapy
- (2018) Jing Wu et al. Frontiers in Pharmacology
- NGAL is Downregulated in Oral Squamous Cell Carcinoma and Leads to Increased Survival, Proliferation, Migration and Chemoresistance
- (2018) Javadi Monisha et al. Cancers
- In Situ Synthesis of Ultrathin ZIF-8 Film-Coated MSNs for Codelivering Bcl 2 siRNA and Doxorubicin to Enhance Chemotherapeutic Efficacy in Drug-Resistant Cancer Cells
- (2018) Qing-Shan Pan et al. ACS Applied Materials & Interfaces
- Development and characterization of a novel cationic PEGylated niosome-encapsulated forms of doxorubicin, quercetin and siRNA for the treatment of cancer by using combination therapy
- (2018) Mahdie Hemati et al. Artificial Cells Nanomedicine and Biotechnology
- siRNA Knockdown of RRM2 Effectively Suppressed Pancreatic Tumor Growth Alone or Synergistically with Doxorubicin
- (2018) Shuquan Zheng et al. Molecular Therapy-Nucleic Acids
- Regulation of Ca2+ Signaling for Drug-Resistant Breast Cancer Therapy with Mesoporous Silica Nanocapsule Encapsulated Doxorubicin/siRNA Cocktail
- (2018) Shu Wang et al. ACS Nano
- The Endosomal Escape of Nanoparticles: Toward More Efficient Cellular Delivery
- (2018) Samuel A. Smith et al. BIOCONJUGATE CHEMISTRY
- Inhibition of cell proliferation through an ATP-responsive co-delivery system of doxorubicin and Bcl-2 siRNA
- (2017) Jianxu Zhang et al. International Journal of Nanomedicine
- VEGF siRNA delivered by polycation liposome-encapsulated calcium phosphate nanoparticles for tumor angiogenesis inhibition in breast cancer
- (2017) Jinliang Chen et al. International Journal of Nanomedicine
- Novel functionalized nanoparticles for tumor-targeting co-delivery of doxorubicin and siRNA to enhance cancer therapy
- (2017) Yu Xia et al. International Journal of Nanomedicine
- Sequential therapy with redox-responsive glucolipid nanocarrier separately delivering siRNA and doxorubicin to overcome multidrug resistance
- (2017) Tingting Meng et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Polymeric nanoparticles for siRNA delivery: Production and applications
- (2017) Gennara Cavallaro et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Fabrication of self-assembled folate–biotin-quaternized starch nanoparticles as co-carrier of doxorubicin and siRNA
- (2017) Liangping Li et al. JOURNAL OF BIOMATERIALS APPLICATIONS
- Nucleolin-Targeting AS1411-Aptamer-Modified Graft Polymeric Micelle with Dual pH/Redox Sensitivity Designed To Enhance Tumor Therapy through the Codelivery of Doxorubicin/TLR4 siRNA and Suppression of Invasion
- (2017) Shudi Yang et al. MOLECULAR PHARMACEUTICS
- Dual role of autophagy in hallmarks of cancer
- (2017) Shikha Satendra Singh et al. ONCOGENE
- Novel targeted therapy for neuroblastoma: silencing the MXD3 gene using siRNA
- (2017) Connie Duong et al. PEDIATRIC RESEARCH
- EphA2 Targeted Doxorubicin-Nanoliposomes for Osteosarcoma Treatment
- (2017) Fateme Haghiralsadat et al. PHARMACEUTICAL RESEARCH
- siRNA-mediated knockdown of ID1 disrupts Nanog- and Oct-4-mediated cancer stem cell-likeness and resistance to chemotherapy in gastric cancer cells
- (2017) Linlin Li et al. Oncology Letters
- HMGB1-mediated autophagy attenuates gemcitabine-induced apoptosis in bladder cancer cells involving JNK and ERK activation
- (2017) Hubin Yin et al. Oncotarget
- Co-delivery of insulin-like growth factor 1 receptor specific siRNA and doxorubicin using chitosan-based nanoparticles enhanced anticancer efficacy in A549 lung cancer cell line
- (2017) Hajar Shali et al. Artificial Cells Nanomedicine and Biotechnology
- Engineered fusion protein-loaded gold nanocarriers for targeted co-delivery of doxorubicin and erbB2-siRNA in human epidermal growth factor receptor-2+ ovarian cancer
- (2017) Rajesh Kotcherlakota et al. Journal of Materials Chemistry B
- The Promising Nanocarrier for Doxorubicin and siRNA Co-delivery by PDMAEMA-based Amphiphilic Nanomicelles
- (2016) Qiang Cheng et al. ACS Applied Materials & Interfaces
- Co-delivery of IL17RB siRNA and doxorubicin by chitosan-based nanoparticles for enhanced anticancer efficacy in breast cancer cells
- (2016) Vahideh Alinejad et al. BIOMEDICINE & PHARMACOTHERAPY
- Phenylboronic acid-functionalized polyamidoamine-mediated Bcl-2 siRNA delivery for inhibiting the cell proliferation
- (2016) Di Wu et al. COLLOIDS AND SURFACES B-BIOINTERFACES
- Reversing of multidrug resistance breast cancer by co-delivery of P-gp siRNA and doxorubicin via folic acid-modified core-shell nanomicelles
- (2016) Yang Wu et al. COLLOIDS AND SURFACES B-BIOINTERFACES
- New insights and evolving role of pegylated liposomal doxorubicin in cancer therapy
- (2016) Alberto A. Gabizon et al. DRUG RESISTANCE UPDATES
- Glucosamine-anchored doxorubicin-loaded targeted nano-niosomes: pharmacokinetic, toxicity and pharmacodynamic evaluation
- (2016) Smita Pawar et al. JOURNAL OF DRUG TARGETING
- Pieter Cullis’ quest for a lipid-based, fusogenic delivery system for nucleic acid therapeutics: success with siRNA so what about mRNA?
- (2016) Ying K. Tam et al. JOURNAL OF DRUG TARGETING
- Effects of HMGA2 siRNA and doxorubicin dual delivery by chitosan nanoparticles on cytotoxicity and gene expression of HT-29 colorectal cancer cell line
- (2016) Homayoon Siahmansouri et al. JOURNAL OF PHARMACY AND PHARMACOLOGY
- Multivalent Aptamer-RNA Conjugates for Simple and Efficient Delivery of Doxorubicin/siRNA into Multidrug-Resistant Cells
- (2016) Hyosook Jeong et al. MACROMOLECULAR BIOSCIENCE
- Comb-like amphiphilic polypeptide-based copolymer nanomicelles for co-delivery of doxorubicin and P-gp siRNA into MCF-7 cells
- (2016) Aili Suo et al. Materials Science & Engineering C-Materials for Biological Applications
- Doxorubicin and siRNA Codelivery via Chitosan-Coated pH-Responsive Mixed Micellar Polyplexes for Enhanced Cancer Therapy in Multidrug-Resistant Tumors
- (2016) Adeel Masood Butt et al. MOLECULAR PHARMACEUTICS
- Multi-Functional Nanogels for Tumor Targeting and Redox-Sensitive Drug and siRNA Delivery
- (2016) Giorgia Adamo et al. MOLECULES
- Lipid Nanoparticle Assisted mRNA Delivery for Potent Cancer Immunotherapy
- (2016) Matthias A. Oberli et al. NANO LETTERS
- The suppression of metastatic lung cancer by pulmonary administration of polymer nanoparticles for co-delivery of doxorubicin and Survivin siRNA
- (2016) Caina Xu et al. Biomaterials Science
- Click modified amphiphilic graft copolymeric micelles of poly(styrene-alt-maleic anhydride) for combinatorial delivery of doxorubicin and plk-1 siRNA in cancer therapy
- (2016) M. R. Aji Alex et al. Journal of Materials Chemistry B
- Galactosylated Liposomes for Targeted Co-Delivery of Doxorubicin/Vimentin siRNA to Hepatocellular Carcinoma
- (2016) Hea Oh et al. Nanomaterials
- Novel polymer micelle mediated co-delivery of doxorubicin and P-glycoprotein siRNA for reversal of multidrug resistance and synergistic tumor therapy
- (2016) Chun-ge Zhang et al. Scientific Reports
- Folate-decorated hydrophilic three-arm star-block terpolymer as a novel nanovehicle for targeted co-delivery of doxorubicin and Bcl-2 siRNA in breast cancer therapy
- (2015) Junmin Qian et al. Acta Biomaterialia
- Dual-targeting and pH/redox-responsive multi-layered nanocomplexes for smart co-delivery of doxorubicin and siRNA
- (2015) Lu Han et al. BIOMATERIALS
- Isorhamnetin augments the anti-tumor effect of capeciatbine through the negative regulation of NF-κB signaling cascade in gastric cancer
- (2015) Kanjoormana A. Manu et al. CANCER LETTERS
- Mitochondrial proteomics with siRNA knockdown to reveal ACAT1 and MDH2 in the development of doxorubicin-resistant uterine cancer
- (2015) Yi-Wen Lo et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Co-delivery of doxorubicin and siRNA for glioma therapy by a brain targeting system: angiopep-2-modified poly(lactic-co-glycolic acid) nanoparticles
- (2015) Lei Wang et al. JOURNAL OF DRUG TARGETING
- Overcoming Akt Induced Therapeutic Resistance in Breast Cancer through siRNA and Thymoquinone Encapsulated Multilamellar Gold Niosomes
- (2015) Shashi Rajput et al. MOLECULAR PHARMACEUTICS
- In Vivo Antitumor Activity of Folate-Conjugated Cholic Acid-Polyethylenimine Micelles for the Codelivery of Doxorubicin and siRNA to Colorectal Adenocarcinomas
- (2015) Muhammad Wahab Amjad et al. MOLECULAR PHARMACEUTICS
- Pulmonary Codelivery of Doxorubicin and siRNA by pH-Sensitive Nanoparticles for Therapy of Metastatic Lung Cancer
- (2015) Caina Xu et al. Small
- Brassinin inhibits STAT3 signaling pathway through modulation of PIAS-3 and SOCS-3 expression and sensitizes human lung cancer xenograft in nude mice to paclitaxel
- (2015) Jong Hyun Lee et al. Oncotarget
- A Light-Driven Therapy of Pancreatic Adenocarcinoma Using Gold Nanorods-Based Nanocarriers for Co-Delivery of Doxorubicin and siRNA
- (2015) Feng Yin et al. Theranostics
- Co-delivery of doxorubicin and P-glycoprotein siRNA by multifunctional triblock copolymers for enhanced anticancer efficacy in breast cancer cells
- (2015) Minghui Xu et al. Journal of Materials Chemistry B
- Bergamottin, a natural furanocoumarin obtained from grapefruit juice induces chemosensitization and apoptosis through the inhibition of STAT3 signaling pathway in tumor cells
- (2014) Sung-Moo Kim et al. CANCER LETTERS
- Improvement of Doxorubicin Efficacy Using Liposomal Anti-Polo-like Kinase 1 siRNA in Human Renal Cell Carcinomas
- (2014) Yu Sakurai et al. MOLECULAR PHARMACEUTICS
- In vivo endothelial siRNA delivery using polymeric nanoparticles with low molecular weight
- (2014) James E. Dahlman et al. Nature Nanotechnology
- Co-Delivery of Doxorubicin and siRNA with Reduction and pH Dually Sensitive Nanocarrier for Synergistic Cancer Therapy
- (2014) Weicai Chen et al. Small
- Co-delivery of Doxorubicin and Bmi1 siRNA by Folate Receptor Targeted Liposomes Exhibits Enhanced Anti-Tumor Effects in vitro and in vivo
- (2014) Tan Yang et al. Theranostics
- Redox-Responsive Mesoporous Silica Nanoparticles: A Physiologically Sensitive Codelivery Vehicle for siRNA and Doxorubicin
- (2013) Xing Ma et al. ANTIOXIDANTS & REDOX SIGNALING
- pH-responsive complexes using prefunctionalized polymers for synchronous delivery of doxorubicin and siRNA to cancer cells
- (2013) Da-Wen Dong et al. BIOMATERIALS
- Capillarisin inhibits constitutive and inducible STAT3 activation through induction of SHP-1 and SHP-2 tyrosine phosphatases
- (2013) Jong Hyun Lee et al. CANCER LETTERS
- Effective response of doxorubicin-sensitive and -resistant breast cancer cells to combinational siRNA therapy
- (2013) Hamidreza Montazeri Aliabadi et al. JOURNAL OF CONTROLLED RELEASE
- Using doxorubicin and siRNA-loaded heptapeptide-conjugated nanoparticles to enhance chemosensitization in epidermal growth factor receptor high-expressed breast cancer cells
- (2013) Chia Wen Liu et al. JOURNAL OF DRUG TARGETING
- Simvastatin sensitizes human gastric cancer xenograft in nude mice to capecitabine by suppressing nuclear factor-kappa B-regulated gene products
- (2013) Kanjoormana A. Manu et al. JOURNAL OF MOLECULAR MEDICINE-JMM
- Doxorubicin: an update on anticancer molecular action, toxicity and novel drug delivery systems
- (2012) Oktay Tacar et al. JOURNAL OF PHARMACY AND PHARMACOLOGY
- Co-delivery of doxorubicin and siRNA using octreotide-conjugated gold nanorods for targeted neuroendocrine cancer therapy
- (2012) Yuling Xiao et al. Nanoscale
- Traceable Multifunctional Micellar Nanocarriers for Cancer-Targeted Co-delivery of MDR-1 siRNA and Doxorubicin
- (2011) Xiao-Bing Xiong et al. ACS Nano
- Light Interactions with Gold Nanorods and Cells: Implications for Photothermal Nanotherapeutics
- (2011) Constantin Ungureanu et al. NANO LETTERS
- Suppression of Signal Transducer and Activator of Transcription 3 Activation by Butein Inhibits Growth of Human Hepatocellular Carcinoma In Vivo
- (2010) Peramaiyan Rajendran et al. CLINICAL CANCER RESEARCH
- Sequential treatment of drug-resistant tumors with RGD-modified liposomes containing siRNA or doxorubicin
- (2010) Juan Jiang et al. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS
- pH-Responsive Polymeric siRNA Carriers Sensitize Multidrug Resistant Ovarian Cancer Cells to Doxorubicin via Knockdown of Polo-like Kinase 1
- (2010) Danielle S. W. Benoit et al. MOLECULAR PHARMACEUTICS
- The forthcoming applications of gold nanoparticles in drug and gene delivery systems
- (2009) Dakrong Pissuwan et al. JOURNAL OF CONTROLLED RELEASE
- Gold Nanorods as Contrast Agents for Biological Imaging: Optical Properties, Surface Conjugation and Photothermal Effects
- (2009) Ling Tong et al. PHOTOCHEMISTRY AND PHOTOBIOLOGY
- Gold nanoparticles in delivery applications☆
- (2008) P GHOSH et al. ADVANCED DRUG DELIVERY REVIEWS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search